Keisuke Tonogaki

Title: Keisuke Tonogaki: Innovator in AMPK-Activating Compounds

Introduction

Keisuke Tonogaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate AMP-activated protein kinase (AMPK). With a total of 4 patents to his name, Tonogaki's work is recognized for its potential therapeutic applications.

Latest Patents

Among his latest patents, Tonogaki has disclosed an azabenzimidazole derivative that exhibits AMPK-activating activity. This compound is described as useful for its role as an AMPK activator, which is crucial in various metabolic processes. The patent details a compound represented by a specific formula, or a pharmaceutically acceptable salt thereof, emphasizing its innovative approach to enhancing AMPK activity.

Career Highlights

Throughout his career, Tonogaki has worked with prominent companies, including Shionogi & Company Limited. His experience in the pharmaceutical industry has allowed him to focus on research and development, leading to his successful patent filings. His contributions have been instrumental in advancing the understanding of AMPK and its implications in health and disease.

Collaborations

Tonogaki has collaborated with esteemed colleagues such as Eiichi Kojima and Nobuyuki Tanaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Keisuke Tonogaki's work in developing AMPK-activating compounds highlights his role as a significant inventor in the pharmaceutical industry. His patents reflect a commitment to advancing medical science and improving therapeutic options for various health conditions.